Strategic Partnerships Opportunity lies in leveraging Second Sight's existing collaborations and exploring co-development with neuromodulation and retinal prosthetics players, hospitals, and research centers to accelerate adoption of Argus II adjuncts and upcoming cortical prosthesis.

Expansion & Access Target North America and international centers that currently offer Argus II to deepen market penetration, expand training programs, and consolidate the standard of care status for severe retinitis pigmentosa through turnkey installation and aftercare packages.

Pipeline monetization Position the Orion cortical prosthesis and other pipeline technologies as premium upgrade paths for existing blind patients and clinics, highlighting longer-term patient outcomes, device durability, and potential for broader eligibility beyond RP.

Digital & Analytics Utilize Second Sight’s AI–driven platform and digital risk insights to offer enterprise security and monitoring services for hospital networks, creating cross-sell opportunities with digital health and data analytics offerings.

Funding & Financing Capitalize on strong funding history to craft financing and reimbursement support for clinics and patients, including bundled procurement, maintenance, and training contracts to improve adoption and cash flow.